The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Intra-Abdominal Fat

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Intra-Abdominal Fat


High impact information on Intra-Abdominal Fat


Chemical compound and disease context of Intra-Abdominal Fat


Biological context of Intra-Abdominal Fat


Anatomical context of Intra-Abdominal Fat


Associations of Intra-Abdominal Fat with chemical compounds


Gene context of Intra-Abdominal Fat


Analytical, diagnostic and therapeutic context of Intra-Abdominal Fat


  1. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Shimomura, I., Funahashi, T., Takahashi, M., Maeda, K., Kotani, K., Nakamura, T., Yamashita, S., Miura, M., Fukuda, Y., Takemura, K., Tokunaga, K., Matsuzawa, Y. Nat. Med. (1996) [Pubmed]
  2. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Schoen, R.E., Weissfeld, J.L., Kuller, L.H., Thaete, F.L., Evans, R.W., Hayes, R.B., Rosen, C.J. Gastroenterology (2005) [Pubmed]
  3. Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation. Kuriyama, H., Yamashita, S., Shimomura, I., Funahashi, T., Ishigami, M., Aragane, K., Miyaoka, K., Nakamura, T., Takemura, K., Man, Z., Toide, K., Nakayama, N., Fukuda, Y., Lin, M.C., Wetterau, J.R., Matsuzawa, Y. Hepatology (1998) [Pubmed]
  4. Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant. Tchernof, A., Starling, R.D., Turner, A., Shuldiner, A.R., Walston, J.D., Silver, K., Poehlman, E.T. Diabetes (2000) [Pubmed]
  5. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Miyazawa-Hoshimoto, S., Takahashi, K., Bujo, H., Hashimoto, N., Saito, Y. Diabetologia (2003) [Pubmed]
  6. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. Walston, J., Silver, K., Bogardus, C., Knowler, W.C., Celi, F.S., Austin, S., Manning, B., Strosberg, A.D., Stern, M.P., Raben, N. N. Engl. J. Med. (1995) [Pubmed]
  7. Skeletal muscle utilization of free fatty acids in women with visceral obesity. Colberg, S.R., Simoneau, J.A., Thaete, F.L., Kelley, D.E. J. Clin. Invest. (1995) [Pubmed]
  8. Visceral abdominal-fat accumulation associated with use of indinavir. Miller, K.D., Jones, E., Yanovski, J.A., Shankar, R., Feuerstein, I., Falloon, J. Lancet (1998) [Pubmed]
  9. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Stranges, S., Dorn, J.M., Muti, P., Freudenheim, J.L., Farinaro, E., Russell, M., Nochajski, T.H., Trevisan, M. Hepatology (2004) [Pubmed]
  10. Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway. Basu, R., Singh, R.J., Basu, A., Chittilapilly, E.G., Johnson, C.M., Toffolo, G., Cobelli, C., Rizza, R.A. Diabetes (2004) [Pubmed]
  11. Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in south Asians and Europeans. McKeigue, P.M., Pierpoint, T., Ferrie, J.E., Marmot, M.G. Diabetologia (1992) [Pubmed]
  12. The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity. Vohl, M.C., Lamarche, B., Moorjani, S., Prud'homme, D., Nadeau, A., Bouchard, C., Lupien, P.J., Després, J.P. Arterioscler. Thromb. Vasc. Biol. (1995) [Pubmed]
  13. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. Franco, C., Brandberg, J., Lönn, L., Andersson, B., Bengtsson, B.A., Johannsson, G. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  14. The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. Dobson, M.G., Redfern, C.P., Unwin, N., Weaver, J.U. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  15. Surgical removal of visceral fat reverses hepatic insulin resistance. Barzilai, N., She, L., Liu, B.Q., Vuguin, P., Cohen, P., Wang, J., Rossetti, L. Diabetes (1999) [Pubmed]
  16. Extreme insulin resistance of the central adipose depot in vivo. Mittelman, S.D., Van Citters, G.W., Kirkman, E.L., Bergman, R.N. Diabetes (2002) [Pubmed]
  17. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Ikezaki, A., Hosoda, H., Ito, K., Iwama, S., Miura, N., Matsuoka, H., Kondo, C., Kojima, M., Kangawa, K., Sugihara, S. Diabetes (2002) [Pubmed]
  18. Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome. Kosmiski, L.A., Kuritzkes, D.R., Lichtenstein, K.A., Glueck, D.H., Gourley, P.J., Stamm, E.R., Scherzinger, A.L., Eckel, R.H. AIDS (2001) [Pubmed]
  19. Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence. Imbeault, P., Prins, J.B., Stolic, M., Russell, A.W., O'Moore-Sullivan, T., Després, J.P., Bouchard, C., Tremblay, A. Diabetes Care (2003) [Pubmed]
  20. Overexpression of muscle uncoupling protein 2 content in human obesity associates with reduced skeletal muscle lipid utilization. Simoneau, J.A., Kelley, D.E., Neverova, M., Warden, C.H. FASEB J. (1998) [Pubmed]
  21. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments. Cnop, M., Landchild, M.J., Vidal, J., Havel, P.J., Knowles, N.G., Carr, D.R., Wang, F., Hull, R.L., Boyko, E.J., Retzlaff, B.M., Walden, C.E., Knopp, R.H., Kahn, S.E. Diabetes (2002) [Pubmed]
  22. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Alessi, M.C., Peiretti, F., Morange, P., Henry, M., Nalbone, G., Juhan-Vague, I. Diabetes (1997) [Pubmed]
  23. Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Buhl, E.S., Jessen, N., Pold, R., Ledet, T., Flyvbjerg, A., Pedersen, S.B., Pedersen, O., Schmitz, O., Lund, S. Diabetes (2002) [Pubmed]
  24. Alterations of insulin sensitivity by the implantation of 3T3-L1 cells in nude mice. A role for TNF-alpha? Shibasaki, M., Takahashi, K., Itou, T., Miyazawa, S., Ito, M., Kobayashi, J., Bujo, H., Saito, Y. Diabetologia (2002) [Pubmed]
  25. Visceral fat, insulin sensitivity, and lipids in prepubertal children. Gower, B.A., Nagy, T.R., Goran, M.I. Diabetes (1999) [Pubmed]
  26. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Carr, D.B., Utzschneider, K.M., Hull, R.L., Kodama, K., Retzlaff, B.M., Brunzell, J.D., Shofer, J.B., Fish, B.E., Knopp, R.H., Kahn, S.E. Diabetes (2004) [Pubmed]
  27. The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans. Andrew, R., Westerbacka, J., Wahren, J., Yki-Järvinen, H., Walker, B.R. Diabetes (2005) [Pubmed]
  28. Longitudinal study on pubertal insulin resistance. Goran, M.I., Gower, B.A. Diabetes (2001) [Pubmed]
  29. Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. Virtanen, K.A., Hällsten, K., Parkkola, R., Janatuinen, T., Lönnqvist, F., Viljanen, T., Rönnemaa, T., Knuuti, J., Huupponen, R., Lönnroth, P., Nuutila, P. Diabetes (2003) [Pubmed]
  30. Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels. Kim, W.S., Fitzgerald, M.L., Kang, K., Okuhira, K., Bell, S.A., Manning, J.J., Koehn, S.L., Lu, N., Moore, K.J., Freeman, M.W. J. Biol. Chem. (2005) [Pubmed]
  31. Growth hormone-releasing hormone and growth hormone-releasing peptide as therapeutic agents to enhance growth hormone secretion in disease and aging. Thorner, M.O., Chapman, I.M., Gaylinn, B.D., Pezzoli, S.S., Hartman, M.L. Recent Prog. Horm. Res. (1997) [Pubmed]
  32. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Després, J.P., Couillard, C., Gagnon, J., Bergeron, J., Leon, A.S., Rao, D.C., Skinner, J.S., Wilmore, J.H., Bouchard, C. Arterioscler. Thromb. Vasc. Biol. (2000) [Pubmed]
  33. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. Draper, N., Echwald, S.M., Lavery, G.G., Walker, E.A., Fraser, R., Davies, E., Sørensen, T.I., Astrup, A., Adamski, J., Hewison, M., Connell, J.M., Pedersen, O., Stewart, P.M. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  34. Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1. Kanaya, A.M., Wassel Fyr, C., Vittinghoff, E., Harris, T.B., Park, S.W., Goodpaster, B.H., Tylavsky, F., Cummings, S.R. Arch. Intern. Med. (2006) [Pubmed]
  35. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. Pasquali, R., Gambineri, A., Biscotti, D., Vicennati, V., Gagliardi, L., Colitta, D., Fiorini, S., Cognigni, G.E., Filicori, M., Morselli-Labate, A.M. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  36. Weight loss reduces interleukin-18 levels in obese women. Esposito, K., Pontillo, A., Ciotola, M., Di Palo, C., Grella, E., Nicoletti, G., Giugliano, D. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  37. Long-term testosterone administration increases visceral fat in female to male transsexuals. Elbers, J.M., Asscheman, H., Seidell, J.C., Megens, J.A., Gooren, L.J. J. Clin. Endocrinol. Metab. (1997) [Pubmed]
WikiGenes - Universities